Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD for THC intoxication in schizophrenia
NCT04605393Completed
- Sponsor
- King's College London
- Start
- Jan 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in schizophrenia comparing CBD/THC with Placebo/THC (2 arms). Primary endpoints: Hopkins Verbal Learning Test and Positive and Negative Syndrome Scale. Started Jan 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT04605393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04605393.